4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-22-084839
Options or other derivatives
- Director acquired 11,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Swirsky Douglas J Director | 2022-06-24 | Grant or award · Stock option (right to buy) | +11,700 | 11,700 | D | ||
Loading xslF345X03/tm2222253-5_4seq1.xml…